Equity Overview
Price & Market Data
Price: $0.66
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $6,887,958
Volume: 0
Performance Metrics
1 Week: 17.90%
1 Month: 8.15%
3 Months: -10.46%
6 Months: -14.29%
1 Year: -36.47%
YTD: -10.46%
Company Details
Employees: 25
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Canada
Details
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.